Showing posts with label insights. Show all posts
Showing posts with label insights. Show all posts

Tuesday, 2 May 2017

Fixed Broadband Market In Australia - Insights, Statistics and Analyses

Researchmoz added Most up-to-date research on "Fixed Broadband Market In Australia - Insights, Statistics and Analyses" to its huge collection of research reports.

Growth in the Australian fixed broadband market has slowed in line with higher penetration rates. Within the market there is a dynamic shift among customers to fibre networks, as this infrastructure is being built out by nbn (NBN Co), the company responsible for the national broadband deployment. While fibre has become by far the fastest growing sector, and DSL is beginning to slide as customers are migrated to the NBN, there is continuing solid growth in the cable broadband sector. This will be supported in coming years when nbn begins to offer commercial services based on the DOCSIS3.1 standard from mid-2017.
Although progress is improving, the fact that the NBN has been a tool for political brinkmanship over the years has cost the country dearly in time and wasted opportunities. Australia ranks relatively low in the global rankings for fixed-line broadband speeds, and during 2015 it fell in a number of tables covering these metrics. Rather than rolling out a first class infrastructure throughout the country, based on FttP, a second rate multi-technology mix has been adopted which incorporates copper infrastructure and assigns fibre to a minority of connections. By contrast, most developed countries have far further advanced their fibre projects, and are fast-tracking infrastructure developments to keep pace with customer demand for high-end IP-delivered services as well as to develop their international competitiveness and digital economies.
The deployment of FttP in greenfield estates is a fast-growing industry, supported by an updated regulatory regime and pricing models. By early June 2016 there were 268,290 greenfield sites passed, of which 162,670 were activated, as well as 1.481 million brownfield sites serviceable, of which 723,440 were activated. As a measure of the speed of deployment reached (compared to the doldrums of 2011), some 31,690 additional lots or premises were passed or covered by the NBN during the last week of May 2016, of which about 25,980 were in brownfield areas and 2,750 in greenfield sites.
The multi-technology NBN has left room for further development in the DSL and cable sectors, both of which are benefiting from the deployment of new technologies. nbn has trialled G.fast technology and expects to provide services based on this upgrade during 2017. HFC is also gaining a new lease of life, with nbn also preparing to trial DOCSIS3.1 technology with a view to commercialising services by mid-2017.


As well as these technological developments, consolidation within the broadband market will provide greater reach and scale for operators in coming years.

Table of Contents
1. General overview and market insights
1.1 Market developments
1.1.1 Broadband statistics
1.1.2 Forecasts - broadband subscribers - 2016; 2018; 2021
1.1.3 Market share by platform
1.2 Access revenues
1.2.1 Statistical overview
1.3 Surveys and statistics
1.3.1 Australian Bureau of Statistics (ABS) Survey - update December 2015
1.3.2 Regional improvements
1.3.3 Statistical information by technology
1.3.4 Broadband speeds
1.3.5 Broadband traffic
1.4 ISP market overview
1.4.1 The market going forward
1.4.2 Data limiting
1.4.3 ISP market statistics
2. Statistical overview of the DSL Market
2.1 Brief overview of the NBN
2.2 Regulatory environment - analysis
2.2.1 The impact of fibre optic networks on digital subscriber line (DSL) regulation
2.2.2 Unbundling of the local loop (ULL) and Bitsream Access
2.2.3 Wholesale DSL pricing
2.3 DSL infrastructure
2.3.1 Overview
2.3.2 Tool for competitors
2.3.3 DSLAM infrastructure
2.3.4 Street cabinet IP DSLAM2 upgrades (Top Hat)
2.3.5 FttN and VDSL
2.3.6 G-fast developments
2.4 Brief overview of broadband providers market
2.4.1 Market consolidation
2.4.2 The shrinking number of ISPs
2.4.3 Market share statistics
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=743777

Friday, 31 March 2017

Pharmaceutical Report On Dakogen - Drug Insights For 2017 | ResearchMoz

Researchmoz added Most up-to-date research on "Pharmaceutical Report On Dakogen - Drug Insights For 2017 | ResearchMoz" to its huge collection of research reports.

The Report will be Dispatched in 3 working days. DelveInsights pharmaceuticals report, Dakogen - Drug Insights, 2014 provides Dakogen marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts. 

Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=218754

Table Of Content

Drug Overview
Global Sales Assessment
Product Description
Mechanism of Action
Pharmacodynamic Properties 
Pharmacokinetic Properties
Marketed Details for the United States 
Marketed Details for the Europe
Patent Information 
Patent and Exclusivity Expiry Assessment United States (US)
Patent Numbers and Expiry Details
Patent Details
Route of Synthesis
Global API Manufacturers Assessment
The United States Drug Master File (US DMF)
The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status 
The Active Pharmaceutical Ingredient (API) Manufacturers by Region
The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
Generic Players
The Pipeline Coverage

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=218754

Competitive Landscape And Analysis Of Xtandi - Drug Insights For 2017

Researchmoz added Most up-to-date research on "Competitive Landscape And Analysis Of Xtandi - Drug Insights For 2017" to its huge collection of research reports.

The Report will be Dispatched in 3 working days. DelveInsights pharmaceuticals report, Xtandi - Drug Insights, 2014 provides Xtandi marketed details and API Manufacturers details across the globe along with the location. In addition, it covers sales estimates for the US, detailed clinical assessment of the drug, patent details, route of synthesis, competitive landscape, and analysis of sales performance during the forecast period (2011-2015). The report also includes SWOT analysis for the drug. This report is built using data and information sourced from DelveInsight proprietary databases, primary and secondary research using Companys corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together with in-house analysis, by DelveInsight team of industry experts. 

Data Sources
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=218765

Table Of Content

Drug Overview
Global Sales Assessment
Product Description
Mechanism of Action
Pharmacodynamic Properties 
Pharmacokinetic Properties
Marketed Details for the United States 
Marketed Details for the Europe
Patent Information 
Patent and Exclusivity Expiry Assessment United States (US)
Patent Numbers and Expiry Details
Patent Details
Route of Synthesis
Global API Manufacturers Assessment
The United States Drug Master File (US DMF)
The Europe Drug Master File (EUDMF)/Active Substance Master File (ASMF)
The Active Pharmaceutical Ingredient (API) Manufacturers in the ASIA Region
The Active Pharmaceutical Ingredient (API) Manufacturers by the United States Drug Master (DMF) File Status 
The Active Pharmaceutical Ingredient (API) Manufacturers by Region
The Active Pharmaceutical Ingredient (API) Manufacturers by Location/Countries
Generic Players
The Pipeline Coverage
Clinical Trials Information
Clinical Trials by Zone
Company Profile
Summary
Company Financials
SWOT Analysis

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=218765

Friday, 24 March 2017

Pipeline Analysis Of Small Cell Lung Cancer (SCLC) Market - Insights, Epidemiology And Forecast To 2023

ResearchMoz presents this most up-to-date research on "Pipeline Analysis Of Small Cell Lung Cancer (SCLC) Market - Insights, Epidemiology And Forecast To 2023".

DelveInsights Small cell lung cancer (SCLC) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Small cell lung cancer (SCLC) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Small cell lung cancer (SCLC) till 2023.

Key Coverage and Benefits


The report will help in developing business strategies by understanding the trends shaping and driving the global Small cell lung cancer (SCLC) market.
Identifying patient populations in the global Small cell lung cancer (SCLC)market to improve product design, pricing, and launch plans.

Organize sales and marketing efforts by identifying the best opportunities for Small cell lung cancer (SCLC) therapeutics in each of the markets covered.
To understand the future market competition in the global Small cell lung cancer (SCLC) therapeutics market and Insightful review of the key market drivers and barriers.

Scope

Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=774518

The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
It also provides Small cell lung cancer (SCLC) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

Table of Contents

Small cell lung cancer (SCLC) overview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Small cell lung cancer (SCLC) Market
Global Epidemiology of Small cell lung cancer (SCLC) Forecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=774518

Treatment And Symptoms Of Glioblastoma multiforme (GBM) Market - Insights, Epidemiology And Forecast To 2023

ResearchMoz presents this most up-to-date research on "Treatment And Symptoms Of Glioblastoma multiforme (GBM) Market - Insights, Epidemiology And Forecast To 2023".

DelveInsights Glioblastoma multiforme (GBM) - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Indication for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Glioblastoma multiforme (GBM) forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Glioblastoma multiforme (GBM) till 2023.

Key Coverage and Benefits


The report will help in developing business strategies by understanding the trends shaping and driving the global Glioblastoma multiforme (GBM) market.
Identifying patient populations in the global Glioblastoma multiforme (GBM)market to improve product design, pricing, and launch plans.

Organize sales and marketing efforts by identifying the best opportunities for Glioblastoma multiforme (GBM) therapeutics in each of the markets covered.

To understand the future market competition in the global Glioblastoma multiforme (GBM) therapeutics market and Insightful review of the key market drivers and barriers.

Scope

Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=774533

The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
It also provides Glioblastoma multiforme (GBM) for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

Table of Contents

Glioblastoma multiforme (GBM) overview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Glioblastoma multiforme (GBM) Market
Global Epidemiology of Glioblastoma multiforme (GBM) Forecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)
Market of Europe
Market of Germany (2013-2015)
Forecasted Market of Germany (2016-2023)
Market of United Kingdom (2013-2015)

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=774533

Thursday, 23 March 2017

Glioblastoma Multiforme Market - Future Demand, Analysis, Insights, Epidemiology & Outlook To 2023

ResearchMoz presents this most up-to-date research on "Glioblastoma Multiforme Market - Future Demand, Analysis, Insights, Epidemiology & Outlook To 2023".

DelveInsights Glioblastoma Multiforme - Market Insights, Epidemiology and Market Forecast-2023 Reports provides an overview of the disease and global market trends of the Glioblastoma Multiforme for the seven major markets ie: United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. The Report covers the therapeutics market revenue; average cost of therapy, treatment practice and Glioblastoma Multiforme forecasted market share for ten years to 2023 segmented by seven major markets. In addition, the report also includes global forecast of epidemiology of Glioblastoma Multiforme till 2023. 

Key Coverage and Benefits
The report will help in developing business strategies by understanding the trends shaping and driving the global Glioblastoma Multiforme market. 
Identifying patient populations in the global Glioblastoma Multiforme market to improve product design, pricing, and launch plans.
Organize sales and marketing efforts by identifying the best opportunities for Glioblastoma Multiforme therapeutics in each of the markets covered.
To understand the future market competition in the global Glioblastoma Multiforme therapeutics market and Insightful review of the key market drivers and barriers.

Scope


Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options. 
Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=774546

The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2013-2023.
It also provides Glioblastoma Multiforme for United States, EU5 and Japan from 2013 and forecasted Market to 2023.

Table of Contents

Glioblastoma Multiforme overview
Pathophysiology
Symptoms of disease
Etiology of disease
Diagnosis of disease
Treatment of disease
Overview of Marketed drugs
Drug Description
Mechanism of Action
Pharmacokinetics Properties
Marketed Details
Patent Information
Patent Exclusivity Expiry Assessment United States (US)
Patents Details
Historical and Forecasted sales of marketed molecules in the Global Glioblastoma Multiforme Market
Global Epidemiology of Glioblastoma Multiforme Forecasted to 2023
Global Market (2013-2015)
Global Forecasted Market (2016-2023)
Global Market by Geography
Market of US (2013-2015)
Forecasted Market of US (2016-2023)
Market of Europe
Market of Germany (2013-2015)
Forecasted Market of Germany (2016-2023)
Market of United Kingdom (2013-2015)
Forecasted Market of United Kingdom (2016-2023)
Market of France (2013-2015)
Forecasted Market of France (2016-2023)
Market of Italy (2013-2015)
Forecasted Market of Italy (2016-2023)

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=774546

Tuesday, 20 December 2016

Expenditure on Infrastructure Construction In Chile

Researchmoz added Most up-to-date research on "Expenditure on Infrastructure Construction In Chile" to its huge collection of research reports.

The report provides a detailed look into the infrastructure sector in Chile, including analysis of the state of the current infrastructure, the regulatory and financing landscapes, and the major projects in the construction pipeline.

The report covers all key infrastructure sectors: roads, railways, electricity and power, water and sewerage, communication, and airports and ports.

Summary
Expenditure on infrastructure construction in Chile is set to grow rapidly over the forecast period (20162020).

According to Timetrics Infrastructure Intelligence Center (IIC), the infrastructure construction markets value rose from US$10.9 billion in 2010 to US$13.4 billion in 2015 and it is anticipated to reach US$17.7 billion by 2020 (in nominal value terms).

This growth is based on the assumption that a number of large-scale infrastructure projects move ahead as planned. These include the Costaera Central Highway, Santiago Metro Line 7, Maria Elena Thermo Solar Park, Acueducto de Aquatacama, Punilla Water Reservoir, the Arturo Merino Benitez International Airport Expansion, and the Puerto de Gran Escala (PGE) San Antonio Development.

Scope
A concise analysis of the administrative, economic and political context for infrastructure in Chile

An in-depth assessment of the current state of infrastructure in Chile, including roads, railways, electricity and power, water and sewerage, communications, airports and ports

To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=892923

A focus on main political and financial institutions involved in the infrastructure market, as well as the competitive and regulatory environment

For each infrastructure sector, an explanation of the key drivers of growth in new investment and an analysis of the project pipeline, with a detailed look at the prospects for major projects and the companies that have secured contracts

Reasons To Buy

Assess the current state of Chile infrastructure, and the main drivers of investment, including the key institutions and financing methods. 

Investigate forecasts and gain an understanding of key trends in each of the main infrastructure sectors.

Analyze the main project participants operating in each sector, to better understand the competitive environment. 

Identify top projects by sector, development stage and start date, to inform expansion strategy.

Key Highlights
Timetric is currently tracking 350 large-scale infrastructure construction projects in Chile, at all stages of development from announcement to execution. These projects have a total investment value of US$140 billion.

The electricity and power sector accounts for the largest share of the project pipeline, with a total project value of US$91.4 billion. This is followed by water and sewerage infrastructure projects, with a pipeline of US$21.3 billion. The pipeline for airports and other infrastructure projects amounts to US$11.4 billion, and for roads it stands at US$9.7 billion. For railway infrastructure construction projects, the total work pipeline stands at US$6.9 billion. 

When compared to other regional peers (Mexico, Brazil and Argentina) through the 2015-2016 World Economic Forums Global Competitive Report, Chile scores 4.6 points higher in terms of overall quality of infrastructure.

Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=892923